Global Nanotechnology-based Drug Delivery Supply, Demand and Key Producers, 2023-2029
The global Nanotechnology-based Drug Delivery market size is expected to reach $ 198210 million by 2029, rising at a market growth of 11.5% CAGR during the forecast period (2023-2029).
This report studies the global Nanotechnology-based Drug Delivery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nanotechnology-based Drug Delivery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nanotechnology-based Drug Delivery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nanotechnology-based Drug Delivery total market, 2018-2029, (USD Million)
Global Nanotechnology-based Drug Delivery total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Nanotechnology-based Drug Delivery total market, key domestic companies and share, (USD Million)
Global Nanotechnology-based Drug Delivery revenue by player and market share 2018-2023, (USD Million)
Global Nanotechnology-based Drug Delivery total market by Type, CAGR, 2018-2029, (USD Million)
Global Nanotechnology-based Drug Delivery total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Nanotechnology-based Drug Delivery market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, lnc., Cristal Therapeutics, EyePoint Pharmaceuticals and Johnson and Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nanotechnology-based Drug Delivery market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nanotechnology-based Drug Delivery Market, By Region:
1. How big is the global Nanotechnology-based Drug Delivery market?
2. What is the demand of the global Nanotechnology-based Drug Delivery market?
3. What is the year over year growth of the global Nanotechnology-based Drug Delivery market?
4. What is the total value of the global Nanotechnology-based Drug Delivery market?
5. Who are the major players in the global Nanotechnology-based Drug Delivery market?
6. What are the growth factors driving the market demand?
This report studies the global Nanotechnology-based Drug Delivery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nanotechnology-based Drug Delivery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nanotechnology-based Drug Delivery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nanotechnology-based Drug Delivery total market, 2018-2029, (USD Million)
Global Nanotechnology-based Drug Delivery total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Nanotechnology-based Drug Delivery total market, key domestic companies and share, (USD Million)
Global Nanotechnology-based Drug Delivery revenue by player and market share 2018-2023, (USD Million)
Global Nanotechnology-based Drug Delivery total market by Type, CAGR, 2018-2029, (USD Million)
Global Nanotechnology-based Drug Delivery total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Nanotechnology-based Drug Delivery market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, lnc., Cristal Therapeutics, EyePoint Pharmaceuticals and Johnson and Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nanotechnology-based Drug Delivery market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nanotechnology-based Drug Delivery Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Nanocrystals
- Nanoparticles
- Liposomes
- Micelles
- Others
- Hospital
- Research Institute
- Others
- AbbVie Inc.
- BlueWillow Biologics Inc.
- Camurus AB
- Celgene, lnc.
- Cristal Therapeutics
- EyePoint Pharmaceuticals
- Johnson and Johnson
1. How big is the global Nanotechnology-based Drug Delivery market?
2. What is the demand of the global Nanotechnology-based Drug Delivery market?
3. What is the year over year growth of the global Nanotechnology-based Drug Delivery market?
4. What is the total value of the global Nanotechnology-based Drug Delivery market?
5. Who are the major players in the global Nanotechnology-based Drug Delivery market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nanotechnology-based Drug Delivery Introduction
1.2 World Nanotechnology-based Drug Delivery Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Nanotechnology-based Drug Delivery Total Market by Region (by Headquarter Location)
1.3.1 World Nanotechnology-based Drug Delivery Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.3 China Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.4 Europe Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.5 Japan Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.6 South Korea Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.7 ASEAN Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.8 India Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nanotechnology-based Drug Delivery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nanotechnology-based Drug Delivery Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.2 World Nanotechnology-based Drug Delivery Consumption Value by Region
2.2.1 World Nanotechnology-based Drug Delivery Consumption Value by Region (2018-2023)
2.2.2 World Nanotechnology-based Drug Delivery Consumption Value Forecast by Region (2024-2029)
2.3 United States Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.4 China Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.5 Europe Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.6 Japan Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.7 South Korea Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.8 ASEAN Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.9 India Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
3 WORLD NANOTECHNOLOGY-BASED DRUG DELIVERY COMPANIES COMPETITIVE ANALYSIS
3.1 World Nanotechnology-based Drug Delivery Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nanotechnology-based Drug Delivery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nanotechnology-based Drug Delivery in 2022
3.2.3 Global Concentration Ratios (CR8) for Nanotechnology-based Drug Delivery in 2022
3.3 Nanotechnology-based Drug Delivery Company Evaluation Quadrant
3.4 Nanotechnology-based Drug Delivery Market: Overall Company Footprint Analysis
3.4.1 Nanotechnology-based Drug Delivery Market: Region Footprint
3.4.2 Nanotechnology-based Drug Delivery Market: Company Product Type Footprint
3.4.3 Nanotechnology-based Drug Delivery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nanotechnology-based Drug Delivery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nanotechnology-based Drug Delivery Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Nanotechnology-based Drug Delivery Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Nanotechnology-based Drug Delivery Consumption Value Comparison
4.2.1 United States VS China: Nanotechnology-based Drug Delivery Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nanotechnology-based Drug Delivery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Nanotechnology-based Drug Delivery Companies and Market Share, 2018-2023
4.3.1 United States Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023)
4.4 China Based Companies Nanotechnology-based Drug Delivery Revenue and Market Share, 2018-2023
4.4.1 China Based Nanotechnology-based Drug Delivery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023)
4.5 Rest of World Based Nanotechnology-based Drug Delivery Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nanotechnology-based Drug Delivery Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Nanocrystals
5.2.2 Nanoparticles
5.2.3 Liposomes
5.2.4 Micelles
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Nanotechnology-based Drug Delivery Market Size by Type (2018-2023)
5.3.2 World Nanotechnology-based Drug Delivery Market Size by Type (2024-2029)
5.3.3 World Nanotechnology-based Drug Delivery Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nanotechnology-based Drug Delivery Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institute
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Nanotechnology-based Drug Delivery Market Size by Application (2018-2023)
6.3.2 World Nanotechnology-based Drug Delivery Market Size by Application (2024-2029)
6.3.3 World Nanotechnology-based Drug Delivery Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Details
7.1.2 AbbVie Inc. Major Business
7.1.3 AbbVie Inc. Nanotechnology-based Drug Delivery Product and Services
7.1.4 AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Inc. Recent Developments/Updates
7.1.6 AbbVie Inc. Competitive Strengths & Weaknesses
7.2 BlueWillow Biologics Inc.
7.2.1 BlueWillow Biologics Inc. Details
7.2.2 BlueWillow Biologics Inc. Major Business
7.2.3 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product and Services
7.2.4 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 BlueWillow Biologics Inc. Recent Developments/Updates
7.2.6 BlueWillow Biologics Inc. Competitive Strengths & Weaknesses
7.3 Camurus AB
7.3.1 Camurus AB Details
7.3.2 Camurus AB Major Business
7.3.3 Camurus AB Nanotechnology-based Drug Delivery Product and Services
7.3.4 Camurus AB Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Camurus AB Recent Developments/Updates
7.3.6 Camurus AB Competitive Strengths & Weaknesses
7.4 Celgene, lnc.
7.4.1 Celgene, lnc. Details
7.4.2 Celgene, lnc. Major Business
7.4.3 Celgene, lnc. Nanotechnology-based Drug Delivery Product and Services
7.4.4 Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Celgene, lnc. Recent Developments/Updates
7.4.6 Celgene, lnc. Competitive Strengths & Weaknesses
7.5 Cristal Therapeutics
7.5.1 Cristal Therapeutics Details
7.5.2 Cristal Therapeutics Major Business
7.5.3 Cristal Therapeutics Nanotechnology-based Drug Delivery Product and Services
7.5.4 Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cristal Therapeutics Recent Developments/Updates
7.5.6 Cristal Therapeutics Competitive Strengths & Weaknesses
7.6 EyePoint Pharmaceuticals
7.6.1 EyePoint Pharmaceuticals Details
7.6.2 EyePoint Pharmaceuticals Major Business
7.6.3 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product and Services
7.6.4 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 EyePoint Pharmaceuticals Recent Developments/Updates
7.6.6 EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Johnson and Johnson
7.7.1 Johnson and Johnson Details
7.7.2 Johnson and Johnson Major Business
7.7.3 Johnson and Johnson Nanotechnology-based Drug Delivery Product and Services
7.7.4 Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Johnson and Johnson Recent Developments/Updates
7.7.6 Johnson and Johnson Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nanotechnology-based Drug Delivery Industry Chain
8.2 Nanotechnology-based Drug Delivery Upstream Analysis
8.3 Nanotechnology-based Drug Delivery Midstream Analysis
8.4 Nanotechnology-based Drug Delivery Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nanotechnology-based Drug Delivery Introduction
1.2 World Nanotechnology-based Drug Delivery Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Nanotechnology-based Drug Delivery Total Market by Region (by Headquarter Location)
1.3.1 World Nanotechnology-based Drug Delivery Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.3 China Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.4 Europe Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.5 Japan Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.6 South Korea Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.7 ASEAN Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.3.8 India Nanotechnology-based Drug Delivery Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nanotechnology-based Drug Delivery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nanotechnology-based Drug Delivery Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.2 World Nanotechnology-based Drug Delivery Consumption Value by Region
2.2.1 World Nanotechnology-based Drug Delivery Consumption Value by Region (2018-2023)
2.2.2 World Nanotechnology-based Drug Delivery Consumption Value Forecast by Region (2024-2029)
2.3 United States Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.4 China Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.5 Europe Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.6 Japan Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.7 South Korea Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.8 ASEAN Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
2.9 India Nanotechnology-based Drug Delivery Consumption Value (2018-2029)
3 WORLD NANOTECHNOLOGY-BASED DRUG DELIVERY COMPANIES COMPETITIVE ANALYSIS
3.1 World Nanotechnology-based Drug Delivery Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Nanotechnology-based Drug Delivery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Nanotechnology-based Drug Delivery in 2022
3.2.3 Global Concentration Ratios (CR8) for Nanotechnology-based Drug Delivery in 2022
3.3 Nanotechnology-based Drug Delivery Company Evaluation Quadrant
3.4 Nanotechnology-based Drug Delivery Market: Overall Company Footprint Analysis
3.4.1 Nanotechnology-based Drug Delivery Market: Region Footprint
3.4.2 Nanotechnology-based Drug Delivery Market: Company Product Type Footprint
3.4.3 Nanotechnology-based Drug Delivery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Nanotechnology-based Drug Delivery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Nanotechnology-based Drug Delivery Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Nanotechnology-based Drug Delivery Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Nanotechnology-based Drug Delivery Consumption Value Comparison
4.2.1 United States VS China: Nanotechnology-based Drug Delivery Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nanotechnology-based Drug Delivery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Nanotechnology-based Drug Delivery Companies and Market Share, 2018-2023
4.3.1 United States Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023)
4.4 China Based Companies Nanotechnology-based Drug Delivery Revenue and Market Share, 2018-2023
4.4.1 China Based Nanotechnology-based Drug Delivery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023)
4.5 Rest of World Based Nanotechnology-based Drug Delivery Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nanotechnology-based Drug Delivery Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Nanocrystals
5.2.2 Nanoparticles
5.2.3 Liposomes
5.2.4 Micelles
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Nanotechnology-based Drug Delivery Market Size by Type (2018-2023)
5.3.2 World Nanotechnology-based Drug Delivery Market Size by Type (2024-2029)
5.3.3 World Nanotechnology-based Drug Delivery Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nanotechnology-based Drug Delivery Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institute
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Nanotechnology-based Drug Delivery Market Size by Application (2018-2023)
6.3.2 World Nanotechnology-based Drug Delivery Market Size by Application (2024-2029)
6.3.3 World Nanotechnology-based Drug Delivery Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Details
7.1.2 AbbVie Inc. Major Business
7.1.3 AbbVie Inc. Nanotechnology-based Drug Delivery Product and Services
7.1.4 AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Inc. Recent Developments/Updates
7.1.6 AbbVie Inc. Competitive Strengths & Weaknesses
7.2 BlueWillow Biologics Inc.
7.2.1 BlueWillow Biologics Inc. Details
7.2.2 BlueWillow Biologics Inc. Major Business
7.2.3 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product and Services
7.2.4 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 BlueWillow Biologics Inc. Recent Developments/Updates
7.2.6 BlueWillow Biologics Inc. Competitive Strengths & Weaknesses
7.3 Camurus AB
7.3.1 Camurus AB Details
7.3.2 Camurus AB Major Business
7.3.3 Camurus AB Nanotechnology-based Drug Delivery Product and Services
7.3.4 Camurus AB Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Camurus AB Recent Developments/Updates
7.3.6 Camurus AB Competitive Strengths & Weaknesses
7.4 Celgene, lnc.
7.4.1 Celgene, lnc. Details
7.4.2 Celgene, lnc. Major Business
7.4.3 Celgene, lnc. Nanotechnology-based Drug Delivery Product and Services
7.4.4 Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Celgene, lnc. Recent Developments/Updates
7.4.6 Celgene, lnc. Competitive Strengths & Weaknesses
7.5 Cristal Therapeutics
7.5.1 Cristal Therapeutics Details
7.5.2 Cristal Therapeutics Major Business
7.5.3 Cristal Therapeutics Nanotechnology-based Drug Delivery Product and Services
7.5.4 Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cristal Therapeutics Recent Developments/Updates
7.5.6 Cristal Therapeutics Competitive Strengths & Weaknesses
7.6 EyePoint Pharmaceuticals
7.6.1 EyePoint Pharmaceuticals Details
7.6.2 EyePoint Pharmaceuticals Major Business
7.6.3 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product and Services
7.6.4 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 EyePoint Pharmaceuticals Recent Developments/Updates
7.6.6 EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Johnson and Johnson
7.7.1 Johnson and Johnson Details
7.7.2 Johnson and Johnson Major Business
7.7.3 Johnson and Johnson Nanotechnology-based Drug Delivery Product and Services
7.7.4 Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Johnson and Johnson Recent Developments/Updates
7.7.6 Johnson and Johnson Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nanotechnology-based Drug Delivery Industry Chain
8.2 Nanotechnology-based Drug Delivery Upstream Analysis
8.3 Nanotechnology-based Drug Delivery Midstream Analysis
8.4 Nanotechnology-based Drug Delivery Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nanotechnology-based Drug Delivery Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Nanotechnology-based Drug Delivery Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Nanotechnology-based Drug Delivery Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nanotechnology-based Drug Delivery Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Nanotechnology-based Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Nanotechnology-based Drug Delivery Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Nanotechnology-based Drug Delivery Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Nanotechnology-based Drug Delivery Players in 2022
Table 12. World Nanotechnology-based Drug Delivery Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Nanotechnology-based Drug Delivery Company Evaluation Quadrant
Table 14. Head Office of Key Nanotechnology-based Drug Delivery Player
Table 15. Nanotechnology-based Drug Delivery Market: Company Product Type Footprint
Table 16. Nanotechnology-based Drug Delivery Market: Company Product Application Footprint
Table 17. Nanotechnology-based Drug Delivery Mergers & Acquisitions Activity
Table 18. United States VS China Nanotechnology-based Drug Delivery Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Nanotechnology-based Drug Delivery Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Nanotechnology-based Drug Delivery Revenue Market Share (2018-2023)
Table 23. China Based Nanotechnology-based Drug Delivery Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Nanotechnology-based Drug Delivery Revenue Market Share (2018-2023)
Table 26. Rest of World Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Nanotechnology-based Drug Delivery Revenue Market Share (2018-2023)
Table 29. World Nanotechnology-based Drug Delivery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Nanotechnology-based Drug Delivery Market Size by Type (2018-2023) & (USD Million)
Table 31. World Nanotechnology-based Drug Delivery Market Size by Type (2024-2029) & (USD Million)
Table 32. World Nanotechnology-based Drug Delivery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Nanotechnology-based Drug Delivery Market Size by Application (2018-2023) & (USD Million)
Table 34. World Nanotechnology-based Drug Delivery Market Size by Application (2024-2029) & (USD Million)
Table 35. AbbVie Inc. Basic Information, Area Served and Competitors
Table 36. AbbVie Inc. Major Business
Table 37. AbbVie Inc. Nanotechnology-based Drug Delivery Product and Services
Table 38. AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. AbbVie Inc. Recent Developments/Updates
Table 40. AbbVie Inc. Competitive Strengths & Weaknesses
Table 41. BlueWillow Biologics Inc. Basic Information, Area Served and Competitors
Table 42. BlueWillow Biologics Inc. Major Business
Table 43. BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product and Services
Table 44. BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. BlueWillow Biologics Inc. Recent Developments/Updates
Table 46. BlueWillow Biologics Inc. Competitive Strengths & Weaknesses
Table 47. Camurus AB Basic Information, Area Served and Competitors
Table 48. Camurus AB Major Business
Table 49. Camurus AB Nanotechnology-based Drug Delivery Product and Services
Table 50. Camurus AB Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Camurus AB Recent Developments/Updates
Table 52. Camurus AB Competitive Strengths & Weaknesses
Table 53. Celgene, lnc. Basic Information, Area Served and Competitors
Table 54. Celgene, lnc. Major Business
Table 55. Celgene, lnc. Nanotechnology-based Drug Delivery Product and Services
Table 56. Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Celgene, lnc. Recent Developments/Updates
Table 58. Celgene, lnc. Competitive Strengths & Weaknesses
Table 59. Cristal Therapeutics Basic Information, Area Served and Competitors
Table 60. Cristal Therapeutics Major Business
Table 61. Cristal Therapeutics Nanotechnology-based Drug Delivery Product and Services
Table 62. Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cristal Therapeutics Recent Developments/Updates
Table 64. Cristal Therapeutics Competitive Strengths & Weaknesses
Table 65. EyePoint Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. EyePoint Pharmaceuticals Major Business
Table 67. EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product and Services
Table 68. EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. EyePoint Pharmaceuticals Recent Developments/Updates
Table 70. Johnson and Johnson Basic Information, Area Served and Competitors
Table 71. Johnson and Johnson Major Business
Table 72. Johnson and Johnson Nanotechnology-based Drug Delivery Product and Services
Table 73. Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 74. Global Key Players of Nanotechnology-based Drug Delivery Upstream (Raw Materials)
Table 75. Nanotechnology-based Drug Delivery Typical Customers
Table 1. World Nanotechnology-based Drug Delivery Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Nanotechnology-based Drug Delivery Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Nanotechnology-based Drug Delivery Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nanotechnology-based Drug Delivery Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Nanotechnology-based Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Nanotechnology-based Drug Delivery Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Nanotechnology-based Drug Delivery Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Nanotechnology-based Drug Delivery Players in 2022
Table 12. World Nanotechnology-based Drug Delivery Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Nanotechnology-based Drug Delivery Company Evaluation Quadrant
Table 14. Head Office of Key Nanotechnology-based Drug Delivery Player
Table 15. Nanotechnology-based Drug Delivery Market: Company Product Type Footprint
Table 16. Nanotechnology-based Drug Delivery Market: Company Product Application Footprint
Table 17. Nanotechnology-based Drug Delivery Mergers & Acquisitions Activity
Table 18. United States VS China Nanotechnology-based Drug Delivery Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Nanotechnology-based Drug Delivery Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Nanotechnology-based Drug Delivery Revenue Market Share (2018-2023)
Table 23. China Based Nanotechnology-based Drug Delivery Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Nanotechnology-based Drug Delivery Revenue Market Share (2018-2023)
Table 26. Rest of World Based Nanotechnology-based Drug Delivery Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Nanotechnology-based Drug Delivery Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Nanotechnology-based Drug Delivery Revenue Market Share (2018-2023)
Table 29. World Nanotechnology-based Drug Delivery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Nanotechnology-based Drug Delivery Market Size by Type (2018-2023) & (USD Million)
Table 31. World Nanotechnology-based Drug Delivery Market Size by Type (2024-2029) & (USD Million)
Table 32. World Nanotechnology-based Drug Delivery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Nanotechnology-based Drug Delivery Market Size by Application (2018-2023) & (USD Million)
Table 34. World Nanotechnology-based Drug Delivery Market Size by Application (2024-2029) & (USD Million)
Table 35. AbbVie Inc. Basic Information, Area Served and Competitors
Table 36. AbbVie Inc. Major Business
Table 37. AbbVie Inc. Nanotechnology-based Drug Delivery Product and Services
Table 38. AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. AbbVie Inc. Recent Developments/Updates
Table 40. AbbVie Inc. Competitive Strengths & Weaknesses
Table 41. BlueWillow Biologics Inc. Basic Information, Area Served and Competitors
Table 42. BlueWillow Biologics Inc. Major Business
Table 43. BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product and Services
Table 44. BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. BlueWillow Biologics Inc. Recent Developments/Updates
Table 46. BlueWillow Biologics Inc. Competitive Strengths & Weaknesses
Table 47. Camurus AB Basic Information, Area Served and Competitors
Table 48. Camurus AB Major Business
Table 49. Camurus AB Nanotechnology-based Drug Delivery Product and Services
Table 50. Camurus AB Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Camurus AB Recent Developments/Updates
Table 52. Camurus AB Competitive Strengths & Weaknesses
Table 53. Celgene, lnc. Basic Information, Area Served and Competitors
Table 54. Celgene, lnc. Major Business
Table 55. Celgene, lnc. Nanotechnology-based Drug Delivery Product and Services
Table 56. Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Celgene, lnc. Recent Developments/Updates
Table 58. Celgene, lnc. Competitive Strengths & Weaknesses
Table 59. Cristal Therapeutics Basic Information, Area Served and Competitors
Table 60. Cristal Therapeutics Major Business
Table 61. Cristal Therapeutics Nanotechnology-based Drug Delivery Product and Services
Table 62. Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cristal Therapeutics Recent Developments/Updates
Table 64. Cristal Therapeutics Competitive Strengths & Weaknesses
Table 65. EyePoint Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. EyePoint Pharmaceuticals Major Business
Table 67. EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product and Services
Table 68. EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. EyePoint Pharmaceuticals Recent Developments/Updates
Table 70. Johnson and Johnson Basic Information, Area Served and Competitors
Table 71. Johnson and Johnson Major Business
Table 72. Johnson and Johnson Nanotechnology-based Drug Delivery Product and Services
Table 73. Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 74. Global Key Players of Nanotechnology-based Drug Delivery Upstream (Raw Materials)
Table 75. Nanotechnology-based Drug Delivery Typical Customers
LIST OF FIGURES
Figure 1. Nanotechnology-based Drug Delivery Picture
Figure 2. World Nanotechnology-based Drug Delivery Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nanotechnology-based Drug Delivery Total Market Size (2018-2029) & (USD Million)
Figure 4. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 13. Nanotechnology-based Drug Delivery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 16. World Nanotechnology-based Drug Delivery Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 18. China Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 23. India Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Nanotechnology-based Drug Delivery by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nanotechnology-based Drug Delivery Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nanotechnology-based Drug Delivery Markets in 2022
Figure 27. United States VS China: Nanotechnology-based Drug Delivery Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nanotechnology-based Drug Delivery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Nanotechnology-based Drug Delivery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Nanotechnology-based Drug Delivery Market Size Market Share by Type in 2022
Figure 31. Nanocrystals
Figure 32. Nanoparticles
Figure 33. Liposomes
Figure 34. Micelles
Figure 35. Others
Figure 36. World Nanotechnology-based Drug Delivery Market Size Market Share by Type (2018-2029)
Figure 37. World Nanotechnology-based Drug Delivery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Nanotechnology-based Drug Delivery Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Research Institute
Figure 41. Others
Figure 42. Nanotechnology-based Drug Delivery Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Nanotechnology-based Drug Delivery Picture
Figure 2. World Nanotechnology-based Drug Delivery Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nanotechnology-based Drug Delivery Total Market Size (2018-2029) & (USD Million)
Figure 4. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Nanotechnology-based Drug Delivery Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Nanotechnology-based Drug Delivery Revenue (2018-2029) & (USD Million)
Figure 13. Nanotechnology-based Drug Delivery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 16. World Nanotechnology-based Drug Delivery Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 18. China Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 23. India Nanotechnology-based Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Nanotechnology-based Drug Delivery by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nanotechnology-based Drug Delivery Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nanotechnology-based Drug Delivery Markets in 2022
Figure 27. United States VS China: Nanotechnology-based Drug Delivery Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nanotechnology-based Drug Delivery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Nanotechnology-based Drug Delivery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Nanotechnology-based Drug Delivery Market Size Market Share by Type in 2022
Figure 31. Nanocrystals
Figure 32. Nanoparticles
Figure 33. Liposomes
Figure 34. Micelles
Figure 35. Others
Figure 36. World Nanotechnology-based Drug Delivery Market Size Market Share by Type (2018-2029)
Figure 37. World Nanotechnology-based Drug Delivery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Nanotechnology-based Drug Delivery Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Research Institute
Figure 41. Others
Figure 42. Nanotechnology-based Drug Delivery Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
